In our study, we selected ESR1, ESR2, and PGR for an in-depth analysis of mRNA expression, genetic alternations, and clinical outcomes as well as the co-expression of these genes with immunomodulatory factors in a variety of cancer types. This evidence concerns the gene ESR2 and cancer.